TY - JOUR T1 - Recent developments in the management of severe asthma JF - Breathe JO - Breathe DO - 10.1183/20734735.0178-2021 VL - 18 IS - 1 SP - 210178 AU - Howraman Meteran AU - Louise Lindhardt Tønnesen AU - Pradeesh Sivapalan AU - Truls Sylvan Ingebrigtsen AU - Jens-Ulrik Stæhr Jensen Y1 - 2022/03/01 UR - http://breathe.ersjournals.com/content/18/1/210178.abstract N2 - Fevipiprant is unlikely to be implemented as a future treatment for severe asthma, while tezepelumab may be a future treatment option for patients with severe asthma with and without eosinophilic inflammation https://bit.ly/3KE1BH4 ER -